![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 2
2022
Ben Khaled, Najib; Hammer, Katharina; Ye, Liangtao; Alnatsha, Ahmed; Widholz, Sebastian A.; Piseddu, Ignazio; Sirtl, Simon; Schneider, Julia; Munker, Stefan; Mahajan, Ujjwal Mukund; Montero, Juan Jose; Griger, Joscha; Mayerle, Julia; Reiter, Florian P. und De Toni, Enrico N.
(2022):
TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status.
In: Cancers, Bd. 14, Nr. 21
[PDF, 2MB]
Falcomata, Chiara; Baerthel, Stefanie; Widholz, Sebastian A.; Schneeweis, Christian; Montero, Juan Jose; Toska, Albulena; Mir, Jonas; Kaltenbacher, Thorsten; Heetmeyer, Jeannine; Swietlik, Jonathan J.; Cheng, Jing-Yuan; Teodorescu, Bianca; Reichert, Oliver; Schmitt, Constantin; Grabichler, Kathrin; Coluccio, Andrea; Boniolo, Fabio; Veltkamp, Christian; Zukowska, Magdalena; Vargas, Angelica Arenas; Paik, Woo Hyun; Jesinghaus, Moritz; Steiger, Katja; Maresch, Roman; Oellinger, Rupert; Ammon, Tim; Baranov, Olga; Robles, Maria S.; Rechenberger, Julia; Kuster, Bernhard; Meissner, Felix; Reichert, Maximilian; Flossdorf, Michael; Rad, Roland; Schmidt-Supprian, Marc; Schneider, Guenter und Saur, Dieter
(2022):
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment.
In: Nature Cancer, Bd. 3, Nr. 3: S. 318-336